雷贝拉唑钠肠溶片治疗老年浅表性胃炎的临床研究

发布时间：2018-03-17 22:27

本文选题：雷贝拉唑钠肠溶片　切入点：老年浅表性胃炎　出处：《临床医药文献电子杂志》2017年70期 　论文类型：期刊论文

【摘要】：目的探究对老年浅表性胃炎患者应用雷贝拉唑钠肠溶片治疗方式实施救治的临床治疗结果。方法选取2016年3月~2017年3月我院收治的老年浅表性胃炎患者94例作为研究对象,均为我院依据相关标准确诊的老年浅表性胃炎患者。并将其随机分为对照组和观察组,各47例。对照组患者给予奥美拉唑肠溶片展开治疗,口服应用,20 mg/次,bid,治疗周期为四周,观察组患者采用雷贝拉唑钠肠溶片治疗方式,口服应用,20 mg/次,bid,治疗周期为四周。观察并比较两组患者临床治疗有效率。结果给予对应治疗方式后,观察组患者临床治疗有效率为95.74%,相较于对照组对应数值85.11%,差异有统计学意义(P0.05)。结论对老年浅表性胃炎患者应用雷贝拉唑钠肠溶片治疗方式实施救治,临床治疗结果显著,对患者临床治疗有效率的提升具有积极作用。
[Abstract]:Objective to investigate the clinical results of treating elderly patients with superficial gastritis with rabeprazole sodium enteric-coated tablets. Methods 94 elderly patients with superficial gastritis admitted in our hospital from March 2016 to March 2017 were selected as study objects. The patients were randomly divided into control group (n = 47) and observation group (n = 47). Patients in the control group were treated with omeprazole enteric-coated tablets for oral administration of 20 mg/ bid for four weeks. The patients in the observation group were treated with rabeprazole sodium enteric-coated tablets orally for 20 mg/. The treatment period was four weeks. The effective rate of clinical treatment was observed and compared between the two groups. The effective rate of clinical treatment in the observation group was 95.74, and the difference was statistically significant compared with the corresponding value of 85.11 in the control group. Conclusion the clinical treatment of senile patients with superficial gastritis treated with rabeprazole sodium enteric-coated tablets has remarkable results. It has a positive effect on the improvement of the effective rate of clinical treatment.
【作者单位】：临沂市兰山区方城中心卫生院;
【分类号】：R573.31

【相似文献】